Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C30H29N5O4S |
| Molecular Weight | 555.647 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C2[C@@H]3CN(CCCCN4C(=O)NC5=C(SC6=C5N=C(C=N6)C7=CC=CC=C7)C4=O)C[C@@H]3COC2=CC=C1
InChI
InChIKey=WDTAYDBPNYFWDR-WOJBJXKFSA-N
InChI=1S/C30H29N5O4S/c1-38-22-10-7-11-23-24(22)20-16-34(15-19(20)17-39-23)12-5-6-13-35-29(36)27-25(33-30(35)37)26-28(40-27)31-14-21(32-26)18-8-3-2-4-9-18/h2-4,7-11,14,19-20H,5-6,12-13,15-17H2,1H3,(H,33,37)/t19-,20-/m1/s1
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effect of food on the pharmacokinetics of fiduxosin in healthy male subjects. | 2002-05-09 |
|
| Effect of fiduxosin, an antagonist selective for alpha(1A)- and alpha(1D)-adrenoceptors, on intraurethral and arterial pressure responses in conscious dogs. | 2002-02 |
|
| Preclinical pharmacology of fiduxosin, a novel alpha(1)-adrenoceptor antagonist with uroselective properties. | 2002-02 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11805207
Fiduxosin had higher affinity for cloned human alpha(1a)- (0.16 nM) and alpha(1d)-adrenoceptors (0.92 nM) in radioligand binding studies compared with alpha(1b)-adrenoceptors (25 nM).
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29713
Created by
admin on Mon Mar 31 18:27:34 GMT 2025 , Edited by admin on Mon Mar 31 18:27:34 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
172307
Created by
admin on Mon Mar 31 18:27:34 GMT 2025 , Edited by admin on Mon Mar 31 18:27:34 GMT 2025
|
PRIMARY | |||
|
208993-54-8
Created by
admin on Mon Mar 31 18:27:34 GMT 2025 , Edited by admin on Mon Mar 31 18:27:34 GMT 2025
|
PRIMARY | |||
|
CHEMBL1256183
Created by
admin on Mon Mar 31 18:27:34 GMT 2025 , Edited by admin on Mon Mar 31 18:27:34 GMT 2025
|
PRIMARY | |||
|
300000034223
Created by
admin on Mon Mar 31 18:27:34 GMT 2025 , Edited by admin on Mon Mar 31 18:27:34 GMT 2025
|
PRIMARY | |||
|
C447622
Created by
admin on Mon Mar 31 18:27:34 GMT 2025 , Edited by admin on Mon Mar 31 18:27:34 GMT 2025
|
PRIMARY | |||
|
C65682
Created by
admin on Mon Mar 31 18:27:34 GMT 2025 , Edited by admin on Mon Mar 31 18:27:34 GMT 2025
|
PRIMARY | |||
|
7951
Created by
admin on Mon Mar 31 18:27:34 GMT 2025 , Edited by admin on Mon Mar 31 18:27:34 GMT 2025
|
PRIMARY | |||
|
DTXSID401017163
Created by
admin on Mon Mar 31 18:27:34 GMT 2025 , Edited by admin on Mon Mar 31 18:27:34 GMT 2025
|
PRIMARY | |||
|
W9O92HYT6I
Created by
admin on Mon Mar 31 18:27:34 GMT 2025 , Edited by admin on Mon Mar 31 18:27:34 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)